Urinary neopterin in patients with liver tumors

Tumori

Volumn 92, Issue 4, 2006, Pages 318-322

  Melichar, Bohuslav ^a   Solichová, Dagmar ^a   Svobodová, Iveta ^a   Urbánek, Lubor ^a   Veselý, Pavel ^a   Melicharová, Karolina ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Liver; Metastases; Neopterin

Indexed keywords

NEOPTERIN;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; ERYTHROCYTE VOLUME; FEMALE; FOLLOW UP; HEMOGLOBIN DETERMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LEUKOCYTE; LIVER TUMOR; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; THROMBOCYTE COUNT; UNIVARIATE ANALYSIS; URINALYSIS;

EID: 33749537896     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160609200410     Document Type: Article

References (26)

1. Pierga JY, Robain M, Jouve M, Asselain B, Dieras V, Beuzeboc P, Palangie T, Dorval T, Extra JM, Scholl S, Pouillart P: Response to chemotherapy is a major parameter-influencing long-term survival of metastatic breast cancer patients. Ann Oncol, 12: 231-237, 2001.
2. Melichar B, Voboril Z, Cerman J, Melicharova K, Nozicka J, Mergancová J, Voboril R, Jandik P: Hepatic arterial infusion chemotherapy in gastric cancer: A report of four cases and analysis of the literature. Tumori, 90: 428-434, 2004.
3. Tournigand C, Andre T, Achille E, Lledo G, Flesch M, Mery-Mignard D, Quinaux E, Couteau C, Buyse M, Ganem G, Landi B, Colin P, Louvet C, de Gramont A: FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol, 22: 229-237, 2004.
4. Zinser JW, Hortobagyi GN, Buzdar AU, Smith TL, Fraschini G: Clinical course of breast cancer patients with liver metastases. J Clin Oncol, 5: 773-782, 1987.
5. Reibnegger G, Fuchs D, Fuith LC, Hausen A, Werner ER, Werner-Felmayer G, Wachter H: Neopterin as a marker for activated cell-mediated immunity: application in malignant disease. Cancer Detect Prev, 15: 483-490, 1991.
6. Wachter H, Fuchs D, Hausen A, Reibnegger G, Werner ER: Neopterin as marker for activation of cellular immunity: immunologic basis and clinical application. Adv Clin Chem, 27: 81-141, 1989.
7. Tsuda Y, Fukuda A, Kobayashi H, Itou D, Yoshimoto S, Iwata K, Hanafusa T: Serum neopterin as a marker for screening of hepatocellular carcinoma. Pteridines, 15: 161-169, 2004.
8. Kawasaki H, Watanabe H, Yamada S, Watanabe K, Suyama A: Prognostic significance of urinary neopterin levels in patients with hepatocellular carcinoma. Tohoku J Exp Med, 155: 311-318, 1988.
9. Yaman H, Cakir E, Ozcan O, Yesilova Z, Ozcan A, Akgul EO, Erbil MK, Bagci S, Bilgi C, Dagalp K: Elevated urine neopterin levels in nonalcoholic steatohepatitis. Clin Biochem, 38: 187-190, 2005.
10. Homann C, Benfield TL, Graudal NA, Garred P: Neopterin and interleukin-8-prognosis in alcohol-induced cirrhosis. Liver, 20: 442-449, 2000.
11. Bengtsson G, Carlsson G, Hafstrom L, Jonsson PE: Natural history of patients with untreated liver metastases from colorectal cancer. Am J Surg, 141: 586-589, 1981.
12. Cermanova M, Melichar B, Solichova D, Blaha M, Blaha V, Blazek M, Masin V, Cerman J, Zadak Z: Urinary neopterin and microalbuminuria in patients treated with low-density lipoprotein apheresis. Pteridines, 16: 174-183, 2005.
13. Solichova D, Melichar B, Blaha V, Klejna M, Vavrova J, Palicka V, Zadak Z: Biochemical profile and survival in nonagenarians. Clin Biochem, 34: 563-569, 2001.
14. Melichar B, Jandik P, Solichova D, Bures J, Lukes J, Mergancova J, Voboril Z: Urinary neopterin excretion in colorectal cancer. Onkologie, 17: 434-436, 1994.
15. Conrad F, Bodner E, Fuchs D, Grubauer G, Hausen A, Reibnegger G, Wachter H: Determination of neopterin - a marker of cellular immunity - in gastrointestinal and pancreatic carcinoma. In: Biochemical and clinical aspects of pteridines, Pfleiderer W, Wachter H, Curtius C (Eds), pp 357-366, Walter de Gruyter, Berlin-New York, 1984.
16. Stangl R, Altendorf-Hofmann A, Charnley RM, Scheele J: Factors influencing the natural history of colorectal liver metastases. Lancet, 343: 1405-1410, 1994.
17. Rougier P, Milan C, Lazorthes F, Fourtanier G, Partensky C, Baumel H, Faivre J: Prospective study of prognostic factors in patients with unresected hepatic metastases from colorectal cancer. Br J Surg, 82: 1397-1400, 1995.
18. Hoe AL, Royle GT, Taylor I: Breast liver metastases - incidence, diagnosis and outcome. J Roy Soc Med, 84: 714-716, 1991.
19. Kemeny N, Braun DW: Prognostic factors in advanced colorectal carcinoma. Importance of lactic dehydrogenase level, performance status, and white blood cell count. Am J Med, 74: 786-794, 1983.
20. Melichar B, Kohlova T, Vesely P: Survival after oxaliplatin therapy of irinotecan-pretreated advanced colorectal cancer patients. Hepatogastroenterology, 52: 1707-1714, 2005.
21. Schennach H, Murr C, Gächter E, Mayersbach P, Schönitzer D, Fuchs D: Factors influencing serum neopterin concentrations in a population of blood donors. Clin Chem, 48: 643-645, 2002.
22. Fahey JL, Schnelle JF, Boscardin J, Thomas JK, Gorre ME, Aziz N, Sadeghi H, Nishanian P: Distinct categories of immunologic changes in frail elderly. Mech Ageing Dev, 115: 1-20, 2000.
23. Fuchs D, Hausen A, Reibnegger G, Werner ER, Werner-Felmayer G, Dierich M, Wachter H: Immune activation and the anaemia associated with chronic inflammatory disorders. Eur J Haematol, 46: 65-70, 1991.
24. Denz H, Fuchs D, Huber H, Nachbaur D, Reibnegger G, Thaler J, Werner ER, Wachter H: Correlation between neopterin, interferon-gamma and haemoglobin in patients with haematological disorders. Eur J Haematol, 44: 186-189, 1990.
25. Wachter H, Artner-Dworzak E, Fuchs D, Fuith LC, Hausen A, Reibnegger G, Werner ER, Werner-Felmayer G, Dierich MP: Association between neopterin and iron metabolism in cancer patients. Tumor Diagn Ther, 11: 229-232, 1990.
26. Kaser A, Brandacher H, Steuer W, Kaser S, Offner FA, Zoller H, Theurl I, Widder W, Molnar C, Ludwiczek O, Atkins MB, Mier JW, Tilg H: Interleukin-6 stimulates trombopoiesis through thrombopoietin: role in inflammatory thrombocytosis. Blood, 98: 2720-2725, 2001.